Publication: The effectiveness of split tablet dosing versus alternate-day dosing of warfarin: a randomized control trial
Issued Date
2021-12-01
Resource Type
ISSN
20452322
Other identifier(s)
2-s2.0-85121361236
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Scientific Reports. Vol.11, No.1 (2021)
Suggested Citation
Chanyapat Kaewsaengeak, Usanee Pienputtarapong, Teerapong Tocharoenchok The effectiveness of split tablet dosing versus alternate-day dosing of warfarin: a randomized control trial. Scientific Reports. Vol.11, No.1 (2021). doi:10.1038/s41598-021-03606-z Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/79183
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The effectiveness of split tablet dosing versus alternate-day dosing of warfarin: a randomized control trial
Other Contributor(s)
Abstract
Due to large dosage variation, a variety of warfarin prescription regimens are utilized for specific doses such as tablet splitting, or pill strength alternating. The clinical comparison between the two is lacking. We hypothesize that both approaches result in different times in therapeutic range. We randomized patients with specific warfarin dosage and stable INR for 6 months or longer to receive the whole tablet, alternate-day dosing or the split tablet, same daily-dosing regimen without initial dose change and followed them every 6 weeks for 6 months. The primary outcome was a time in therapeutic range of 2.0–3.0. The secondary outcomes included dosage, compliance, INR, anticoagulant-related events. A total of 66 patients were enrolled, 32 randomly assigned to the split tablet regimen (group S) and 34 to the alternate-day regimen (group A) with two withdrawers. The mean age was 58.6 ± 8.5 years. All baseline characteristics of both groups were similar. The average time in therapeutic range was 72.8 ± 25.4% in group S and 74.9 ± 22.0% in group A (p = 0.72). There were no significant differences in warfarin dosage, compliance, INR and, complications between the two groups. Both warfarin prescription methods, the split tablet and the alternate-day had comparable time in the therapeutic range.